GB202117511D0 - Treatment regimens - Google Patents

Treatment regimens

Info

Publication number
GB202117511D0
GB202117511D0 GBGB2117511.2A GB202117511A GB202117511D0 GB 202117511 D0 GB202117511 D0 GB 202117511D0 GB 202117511 A GB202117511 A GB 202117511A GB 202117511 D0 GB202117511 D0 GB 202117511D0
Authority
GB
United Kingdom
Prior art keywords
treatment regimens
regimens
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2117511.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionctura SA
Original Assignee
Ionctura SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ionctura SA filed Critical Ionctura SA
Priority to GBGB2117511.2A priority Critical patent/GB202117511D0/en
Publication of GB202117511D0 publication Critical patent/GB202117511D0/en
Priority to AU2022250707A priority patent/AU2022250707A1/en
Priority to EP22719266.3A priority patent/EP4313058A1/en
Priority to US18/271,196 priority patent/US20240058351A1/en
Priority to CA3212522A priority patent/CA3212522A1/en
Priority to CN202280022613.8A priority patent/CN116997340A/en
Priority to PCT/EP2022/058283 priority patent/WO2022207646A1/en
Priority to CN202280022612.3A priority patent/CN117042778A/en
Priority to PCT/EP2022/058296 priority patent/WO2022207648A1/en
Priority to CA3212731A priority patent/CA3212731A1/en
Priority to JP2023560325A priority patent/JP2024511836A/en
Priority to JP2023560623A priority patent/JP2024518685A/en
Priority to EP22719273.9A priority patent/EP4313059A1/en
Priority to AU2022251843A priority patent/AU2022251843A1/en
Ceased legal-status Critical Current

Links

GBGB2117511.2A 2021-03-29 2021-12-03 Treatment regimens Ceased GB202117511D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB2117511.2A GB202117511D0 (en) 2021-12-03 2021-12-03 Treatment regimens
AU2022251843A AU2022251843A1 (en) 2021-03-29 2022-03-29 <i>A PI3K-DELTA INHIBITOR FOR USE IN TREATMENT REGIMENS</i>
PCT/EP2022/058283 WO2022207646A1 (en) 2021-03-29 2022-03-29 A pi3k-delta inhibitor for use in treatment regimens
PCT/EP2022/058296 WO2022207648A1 (en) 2021-03-29 2022-03-29 A pi3k-delta inhibitor for the treatment of pancreatic cancer
US18/271,196 US20240058351A1 (en) 2021-03-29 2022-03-29 A pi3k-delta inhibitor for use in treatment regimens
CA3212522A CA3212522A1 (en) 2021-03-29 2022-03-29 A pi3k-delta inhibitor for the treatment of pancreatic cancer
CN202280022613.8A CN116997340A (en) 2021-03-29 2022-03-29 PI 3K-delta inhibitors for the treatment of pancreatic cancer
AU2022250707A AU2022250707A1 (en) 2021-03-29 2022-03-29 A pi3k-delta inhibitor for the treatment of pancreatic cancer
CN202280022612.3A CN117042778A (en) 2021-03-29 2022-03-29 PI 3K-delta inhibitors for therapeutic regimens
EP22719266.3A EP4313058A1 (en) 2021-03-29 2022-03-29 A pi3k-delta inhibitor for use in treatment regimens
CA3212731A CA3212731A1 (en) 2021-03-29 2022-03-29 A pi3k-delta inhibitor for use in treatment regimens
JP2023560325A JP2024511836A (en) 2021-03-29 2022-03-29 PI3K-delta inhibitors for the treatment of pancreatic cancer
JP2023560623A JP2024518685A (en) 2021-03-29 2022-03-29 PI3K-DELTA INHIBITORS FOR USE IN TREATMENT REGIMENS - Patent application
EP22719273.9A EP4313059A1 (en) 2021-03-29 2022-03-29 A pi3k-delta inhibitor for the treatment of pancreatic cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2117511.2A GB202117511D0 (en) 2021-12-03 2021-12-03 Treatment regimens

Publications (1)

Publication Number Publication Date
GB202117511D0 true GB202117511D0 (en) 2022-01-19

Family

ID=80081011

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2117511.2A Ceased GB202117511D0 (en) 2021-03-29 2021-12-03 Treatment regimens

Country Status (2)

Country Link
CN (2) CN117042778A (en)
GB (1) GB202117511D0 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5735526B2 (en) * 2009-11-13 2015-06-17 メルク セローノ ソシエテ アノニム Tricyclic pyrazoleamine derivatives
WO2014121901A1 (en) * 2013-02-07 2014-08-14 Merck Patent Gmbh Polymorphic forms

Also Published As

Publication number Publication date
CN116997340A (en) 2023-11-03
CN117042778A (en) 2023-11-10

Similar Documents

Publication Publication Date Title
IL272738A (en) Treatment regimens
GB202108224D0 (en) Treatment
GB202103122D0 (en) Treatment
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GB202117511D0 (en) Treatment regimens
IL304244A (en) Synbiotic treatment regimens
GB202112635D0 (en) Treatment regimen
GB202019215D0 (en) Treatment regimen
GB202017853D0 (en) Treatment regimen
GB202116743D0 (en) Treatment
GB202008478D0 (en) Treatment regimen
GB202114373D0 (en) Treatment
GB202109815D0 (en) Treatment
GB202109812D0 (en) Treatment
GB202104666D0 (en) COVID-19 treatment
GB202104416D0 (en) Treatment reginmens
GB202103957D0 (en) Treatment
GB202102488D0 (en) Treatment
GB202102369D0 (en) Treatment
GB202102366D0 (en) Treatment
GB202102373D0 (en) Treatment
GB202102410D0 (en) Treatment
GB202101897D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)